Respiratory therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Global and Japan Bovine Respiratory Disease Treatment Market Size, Status and Forecast 2021-2027By QYResearch Group "...... e able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type......" | 05-Oct-2021 | $3900 | |
Global Respiratory Drugs Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 CountriesBy Maia Research "...... scape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Respiratory Drugs industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis and market entry s......" | 05-Oct-2021 | $4000 | |
United States Ambroxol Market Report & Forecast 2021-2027By QYResearch Group "...... ns) & (K Pcs)
United States Ambroxol Market Segment Percentages, By Application, 2020 (%)
- Acute Respiratory Diseases
- Chronic Respiratory Diseases
Competitor Analysis
The report also provides analysis of ......" | 30-Sep-2021 | $3400 | |
Global and China Carbocisteine Market Insights, Forecast to 2027By QYResearch Group "...... d not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. In this report, we study the Carbocisteine API.
Global Carbocisteine key players include Moehs Iberica, Wuhan Grand Hoyo, Afton Pharma, Jinshi ......" | 10-Sep-2021 | $3900 | |
Carbocisteine Market - Global Outlook and Forecast 2021-2027By Market Monitor Global "...... eine companies in 2020 (%)
The global Carbocisteine market was valued at 58 million in 2020 and is projected to reach US$ 69 million by 2027, at a CAGR of 4.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surve......" | 09-Sep-2021 | $3250 | |
United States Carbocisteine Market Report & Forecast 2021-2027By QYResearch Group "...... ions) & (MT)
United States Carbocisteine Market Segment Percentages, By Application, 2020 (%)
- Oral Solution
- Tablet & Capsule
- Others
Competitor Analysis
The report also provides analysis of leadi......" | 09-Sep-2021 | $3400 | |
Bronchiectasis (Respiratory) - Drugs In Development, 2021By Global Markets Direct "...... onchiectasis is a chronic condition where the walls of the bronchial tubes are permanently damaged. These damage allow bacteria and mucus to build up in lungs. Bronchiectasis is divided into two categories cystic fibrosis (CF) bronchiectasis and non-......" | 30-Aug-2021 | $2000 | |
Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) - Drugs In Development, 2021By Global Markets Direct "...... he Chronic Obstructive Pulmonary Disease (Respiratory) pipeline landscape.Chronic obstructive pulmonary disease (COPD) is a group of lung diseases. It is characterized by inability to completely breathe out air from the lungs leading to shortness of ......" | 30-Aug-2021 | $2500 | |
Idiopathic Pulmonary Fibrosis (Respiratory) - Drugs In Development, 2021By Global Markets Direct "...... Fibrosis (Respiratory) pipeline landscape.Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease characterized by inflammation and scarring of lung tissue and loss of lung function. Symptoms of IPF include dry cough, shortness of bre......" | 30-Aug-2021 | $2500 | |
Asthma (Respiratory) - Drugs In Development, 2021By Global Markets Direct "...... e involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. Symptoms include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The ......" | 30-Aug-2021 | $2500 | |
|